Indegene Limited

NSE INDGN.NS

Indegene Limited Market Capitalization on January 14, 2025: USD 1.78 B

Indegene Limited Market Capitalization is USD 1.78 B on January 14, 2025, a 8.98% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Indegene Limited 52-week high Market Capitalization is USD 2.02 B on October 01, 2024, which is 13.39% above the current Market Capitalization.
  • Indegene Limited 52-week low Market Capitalization is USD 1.42 B on June 04, 2024, which is -20.64% below the current Market Capitalization.
  • Indegene Limited average Market Capitalization for the last 52 weeks is USD 1.72 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
NSE: INDGN.NS

Indegene Limited

CEO Mr. Manish Gupta BTech, MBA
IPO Date May 13, 2024
Location India
Headquarters Manyata Embassy Business Park
Employees 4,367
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.

StockViz Staff

January 15, 2025

Any question? Send us an email